If enacted, funding could provide for upwards of 100,000 additional units of donated cord blood to be potentially used in allogeneic (non-family related) transplants. The IOM report also recommends establishment of a policy board to adopt more rigorous quality standards with respect to cord blood products.
Cryo-Cell said it believes that the IOM report underscores the message that it has been delivering to clinicians and expectant parents “for well over a decade – that cord blood stem cells save lives.”